Kenalog and Silvadene drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Kenalog (triamcinolone acetonide) and Silvadene (silver sulfadiazine). Common drug interactions include back pain among females and atrial fibrillation among males.

The phase IV clinical study analyzes what interactions people have when they take Kenalog and Silvadene. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Kenalog?

Kenalog has active ingredients of triamcinolone acetonide. It is often used in pain. eHealthMe is studying from 10,692 Kenalog users. Check the latest studies of Kenalog.

What is Silvadene?

Silvadene has active ingredients of silver sulfadiazine. eHealthMe is studying from 1,161 Silvadene users. Check the latest studies of Silvadene.



On Jul, 07, 2026

15 people who take Kenalog and Silvadene together, and have interactions are studied.

Kenalog and Silvadene drug interactions.

What are the common drug interactions of Kenalog and Silvadene, by gender? *:

female:

  1. Back pain
  2. Cough
  3. Back injury
  4. Fatigue (feeling of tiredness)
  5. Weight increased
  6. Arthralgia (joint pain)
  7. Bronchitis chronic (inflammation of the mucous membrane in the bronchial tubes- chronic)
  8. Cardiac murmur (an heart sound in valve abnormality)
  9. Cystitis interstitial (unknown cause characterized by bladder pain)
  10. Fall

male:

  1. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  2. Chronic kidney disease
  3. Scab (a hard coating on the skin formed during the wound healing)
  4. Skin ulcer
  5. Subdural haematoma (blood collects between the skull and the surface of the brain)
  6. Coagulopathy (blood's ability to clot is impaired)
  7. Eye pruritus (eye itching)
  8. Increased tendency to bruise (increased tendency to injure the underlying soft tissue or bone)
  9. Penile ulceration
  10. Peripheral vascular disorder

What are the common drug interactions of Kenalog and Silvadene, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Back injury
  2. Back pain
  3. Weight increased
  4. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
  5. Chronic kidney disease
  6. Cough
  7. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  8. Facet joint syndrome (problem with movement of the facet joints of the spine)
  9. Hyperglycaemia (high blood sugar)
  10. Hypoaesthesia (reduced sense of touch or sensation)

60+:

  1. Fall
  2. Fracture delayed union (delayed cure of broken bone)
  3. Diverticulum intestinal haemorrhagic (a pouch that is attached to the first part of the small intestine with bleeding)
  4. Fatigue (feeling of tiredness)
  5. Headache (pain in head)
  6. Herpes zoster
  7. Hypoglycaemia (deficiency of glucose in the bloodstream)
  8. Hypophagia (reduced food intake)
  9. Injection site pain
  10. Insomnia (sleeplessness)

What are the existing conditions these people have? *

  1. High Blood Pressure: 4 people, 26.67%
  2. Hypersensitivity: 3 people, 20.00%
  3. Diabetes: 3 people, 20.00%
  4. Affective Disorder (mental disorder): 2 people, 13.33%
  5. Cough: 2 people, 13.33%
  6. Wheezing (a high-pitched whistling sound made while you breath): 2 people, 13.33%
  7. Mood Swings (an extreme or rapid change in mood): 2 people, 13.33%
  8. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 13.33%
  9. Discomfort: 2 people, 13.33%
  10. Depression: 2 people, 13.33%

* Approximation only. Some reports may have incomplete information.

Do you take Kenalog and Silvadene?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Kenalog and Silvadene:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Kenalog:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Silvadene:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Kenalog and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Silvadene and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on triamcinolone acetonide and silver sulfadiazine (the active ingredients of Kenalog and Silvadene, respectively), and Kenalog and Silvadene (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: